Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has shared an announcement.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is undergoing a proposed pre-conditional privatization by Sunshine Lake Pharma Co., Ltd. through a merger by absorption. The merger is contingent upon fulfilling several pre-conditions, including obtaining necessary governmental approvals and listing permissions. As of the latest update, the NDRC approval has been obtained, but other approvals and conditions are still pending. The merger’s completion remains uncertain, and stakeholders are advised to stay informed about further announcements regarding the fulfillment of these conditions.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company based in China, focusing on the development, production, and sale of pharmaceutical products. The company operates within the healthcare industry, serving both domestic and international markets.
YTD Price Performance: -2.09%
Average Trading Volume: 3,297,522
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.24B
Find detailed analytics on 1558 stock on TipRanks’ Stock Analysis page.